Article info
Original article
High CCL27 immunoreactivity in ‘supratumoral’ epidermis correlates with better prognosis in patients with cutaneous malignant melanoma
- Correspondence to Dr Miguel Martinez-Rodriguez, Department of Pathology, Telemark Hospital, Ulefossveien 55, Skien 3710, Norway; mimarro111{at}hotmail.com
Citation
High CCL27 immunoreactivity in ‘supratumoral’ epidermis correlates with better prognosis in patients with cutaneous malignant melanoma
Publication history
- Received November 30, 2015
- Revised April 12, 2016
- Accepted April 30, 2016
- First published June 20, 2016.
Online issue publication
June 14, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/